QUANTUM BIOPHARMA-B SUB VOT (QNTM) Stock Balance Sheet
USA - NASDAQ:QNTM - CA74764Y2050 - Common Stock
6.79 USD
-0.42 (-5.83%)
6.7 USD
-0.09 (-1.33%)
| MRQ (2025-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | 35.26M | 17.52M | 5.94M | 15.83M | |||
| Cash Equivalents | 1.50M | null | null | null | null | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 30.80K | 158.00K | null | null | null | |||
| Receivables | 3.23M | 501.00K | 161.30K | 1.55M | 736.00K | |||
| Inventories | 76.90K | null | 0 | 706.30K | null | |||
| Other Current Assets | 5.51M | 10.01M | 9.18M | 322.40K | 338.90K | |||
| Total Current Assets | 10.34M | 45.93M | 26.87M | 8.52M | 16.91M | |||
| Non-Current Assets | ||||||||
| PPE Net | 228.20K | 168.30K | 0 | 8.94M | 9.09M | |||
| Investments And Advances | 0 | 660.20K | 1.68M | 8.82M | 13.53M | |||
| Goodwill | null | null | null | null | null | |||
| Intangibles | 4.73M | 16.20M | 13.42M | 16.75M | null | |||
| Other Non-Current Assets | null | null | null | null | null | |||
| Total Non-Current Assets | 4.95M | 17.03M | 15.10M | 34.51M | 22.62M | |||
| TOTAL ASSETS | 15.30M | 62.96M | 41.97M | 43.03M | 39.53M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 2.11M | 300.60K | 384.70K | 1.43M | 0 | |||
| Current Portion Of LT Debt. | 156.60K | 124.30K | 46.80K | 42.10K | null | |||
| Accrued Expenses | 1.32M | 4.46M | null | null | null | |||
| Accounts Payable | 1.87M | 3.00M | 3.70M | 3.35M | null | |||
| Other Current Liabilities | 7.79M | 825.10K | 1.45M | 1.98M | 1.31M | |||
| Total Current Liabilities | 13.25M | 8.70M | 5.58M | 6.80M | 1.31M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 131.10K | 79.10K | 109.80K | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | null | null | null | null | null | |||
| Total Non-Current Liabilities | -1.72M | 131.10K | 79.10K | 109.90K | 0 | |||
| TOTAL LIABILITIES | 11.53M | 8.83M | 5.66M | 6.91M | 1.31M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -188.91M | -121.02M | -85.90M | -54.51M | -16.53M | |||
| Additional Paid In Capital | 32.58M | 22.58M | 18.79M | 17.30M | 3.73M | |||
| Minority Interest | -1.72M | null | null | null | null | |||
| Common Shares | 159.96M | 152.32M | 103.21M | 73.42M | 51.02M | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | 130.90K | 239.60K | 207.80K | -84.40K | null | |||
| Shares Outstanding | 3.47M | 622.20K | 294.80K | 7.91M | 6.85M | |||
| Tangible Book Value per Share | -0.2772 | 60.96 | 77.6314 | 2.4503 | 5.5796 | |||
| Total Shareholders' Equity | 3.76M | 54.13M | 36.31M | 36.12M | 38.22M | |||
| TOTAL LIABILITIES AND EQUITY | 15.30M | 62.96M | 41.97M | 43.03M | 39.53M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.01 | 0.01 | 0.04 | N/A | |||
| Current Ratio | 0.78 | 5.28 | 4.82 | 1.25 | 12.94 | |||
| Return On Assets (ROA) | -173.82% | -56.04% | -75.77% | -87.96% | -43.03% | |||
| Return On Equity (ROE) | -706.43% | -65.19% | -87.58% | -104.79% | -44.50% | |||
All data in USD , ROIC based on taxRate of 0.25